EMPIRE STATE REALTY TRUST-A (ESRT) Fundamental Analysis & Valuation

NYSE:ESRTUS2921041065

Current stock price

5.17 USD
+0.09 (+1.77%)
At close:
5.17 USD
0 (0%)
After Hours:

This ESRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ESRT Profitability Analysis

1.1 Basic Checks

  • ESRT had positive earnings in the past year.
  • In the past year ESRT had a positive cash flow from operations.
  • ESRT had positive earnings in 4 of the past 5 years.
  • ESRT had a positive operating cash flow in each of the past 5 years.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • ESRT has a Return On Assets of 0.97%. This is comparable to the rest of the industry: ESRT outperforms 54.47% of its industry peers.
  • ESRT's Return On Equity of 3.98% is fine compared to the rest of the industry. ESRT outperforms 60.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.50%, ESRT is in line with its industry, outperforming 46.34% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.13%.
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROIC 2.5%
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

1.3 Margins

  • ESRT has a Profit Margin (5.65%) which is comparable to the rest of the industry.
  • ESRT's Profit Margin has improved in the last couple of years.
  • ESRT has a Operating Margin (17.66%) which is in line with its industry peers.
  • ESRT's Operating Margin has improved in the last couple of years.
  • ESRT's Gross Margin of 53.70% is on the low side compared to the rest of the industry. ESRT is outperformed by 75.61% of its industry peers.
  • ESRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. ESRT Health Analysis

2.1 Basic Checks

  • ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ESRT has more shares outstanding
  • ESRT has less shares outstanding than it did 5 years ago.
  • ESRT has a better debt/assets ratio than last year.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • ESRT has an Altman-Z score of 0.48. This is a bad value and indicates that ESRT is not financially healthy and even has some risk of bankruptcy.
  • ESRT has a Altman-Z score (0.48) which is comparable to the rest of the industry.
  • ESRT has a Debt/Equity ratio of 2.18. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 2.18, ESRT is doing worse than 69.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACC0.43
WACC5.76%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ESRT has a Current Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.34, ESRT belongs to the best of the industry, outperforming 91.06% of the companies in the same industry.
  • ESRT has a Quick Ratio of 2.34. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ESRT (2.34) is better than 91.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. ESRT Growth Analysis

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.10%, which is quite impressive.
  • ESRT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.42% yearly.
  • ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
  • ESRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.75% yearly.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%

3.2 Future

  • ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -39.35% yearly.
  • Based on estimates for the next years, ESRT will show a small growth in Revenue. The Revenue will grow by 2.24% on average per year.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. ESRT Valuation Analysis

4.1 Price/Earnings Ratio

  • ESRT is valuated cheaply with a Price/Earnings ratio of 5.94.
  • ESRT's Price/Earnings ratio is rather cheap when compared to the industry. ESRT is cheaper than 98.37% of the companies in the same industry.
  • ESRT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.54.
  • With a Price/Forward Earnings ratio of 84.48, ESRT can be considered very expensive at the moment.
  • ESRT's Price/Forward Earnings is on the same level as the industry average.
  • ESRT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 5.94
Fwd PE 84.48
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 86.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.41
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ESRT's earnings are expected to decrease with -61.15% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

3

5. ESRT Dividend Analysis

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.71%. Purely for dividend investing, there may be better candidates out there.
  • With a Dividend Yield of 2.71, ESRT pays less dividend than the industry average, which is at 7.32. 80.49% of the companies listed in the same industry pay a better dividend than ESRT!
  • ESRT's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.71%

5.2 History

  • The dividend of ESRT decreases each year by -6.73%.
  • ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-6.73%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • ESRT pays out 64.35% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP64.35%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

ESRT Fundamentals: All Metrics, Ratios and Statistics

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (3/23/2026, 8:04:00 PM)

After market: 5.17 0 (0%)

5.17

+0.09 (+1.77%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners103.01%
Inst Owner Change1.34%
Ins Owners0.08%
Ins Owner Change0.04%
Market Cap885.31M
Revenue(TTM)768.27M
Net Income(TTM)43.40M
Analysts75
Price Target7.51 (45.26%)
Short Float %5.37%
Short Ratio5.47
Dividend
Industry RankSector Rank
Dividend Yield 2.71%
Yearly Dividend0.17
Dividend Growth(5Y)-6.73%
DP64.35%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.54%
PT rev (3m)-14.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.94
Fwd PE 84.48
P/S 1.15
P/FCF N/A
P/OCF 3.55
P/B 0.81
P/tB 3.02
EV/EBITDA 9.41
EPS(TTM)0.87
EY16.83%
EPS(NY)0.06
Fwd EY1.18%
FCF(TTM)-2.11
FCFYN/A
OCF(TTM)1.45
OCFY28.13%
SpS4.49
BVpS6.36
TBVpS1.71
PEG (NY)N/A
PEG (5Y)0.1
Graham Number11.16
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 3.98%
ROCE 3.16%
ROIC 2.5%
ROICexc 2.58%
ROICexgc 3.19%
OM 17.66%
PM (TTM) 5.65%
GM 53.7%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)4.43%
ROE(5y)3.19%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF N/A
Debt/EBITDA 7.18
Cap/Depr 313.47%
Cap/Sales 79.47%
Interest Coverage 1.45
Cash Conversion 75.38%
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 0.48
F-Score6
WACC5.76%
ROIC/WACC0.43
Cap/Depr(3y)200.4%
Cap/Depr(5y)163.62%
Cap/Sales(3y)50.04%
Cap/Sales(5y)43.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-14.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y-231.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.54%
OCF growth 3Y5.65%
OCF growth 5Y6.44%

EMPIRE STATE REALTY TRUST-A / ESRT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 5.94 and the Price/Book (PB) ratio is 0.81.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.